| meta-analysis | Q815382 |
| scholarly article | Q13442814 |
| P50 | author | Annelies E de Weerd | Q90252741 |
| P2093 | author name string | Michiel G H Betjes | |
| P2860 | cites work | Meta-analysis of Observational Studies in Epidemiology: A Proposal for Reporting | Q27861077 |
| ABO incompatible kidney transplantation - an analysis of UNOS Registry data | Q31034921 | ||
| One-year protocol biopsies from ABO-incompatible renal allografts compared with a matched cohort of ABO-compatible allografts | Q35565364 | ||
| Outcomes of ABO-incompatible kidney transplantation in the United States | Q35822937 | ||
| Low dose of mycophenolate mofetil is enough in desensitized kidney transplantation using rituximab | Q35861272 | ||
| Outcome after Desensitization in HLA or ABO-Incompatible Kidney Transplant Recipients: A Single Center Experience. | Q35885244 | ||
| Risk Factors for Graft Failure and Death following Geriatric Renal Transplantation | Q35988433 | ||
| Excellent long term patient and renal allograft survival after ABO-incompatible kidney transplantation: Experience of one center | Q36400872 | ||
| Early post-transplant complications following ABO-incompatible kidney transplantation | Q36683142 | ||
| ABO-incompatible renal transplantation in developing world - crossing the immunological (and mental) barrier. | Q36696495 | ||
| Comparison of clinical outcomes between ABO-compatible and ABO-incompatible spousal donor kidney transplantation | Q36740471 | ||
| Economic Impacts of ABO-Incompatible Live Donor Kidney Transplantation: A National Study of Medicare-Insured Recipients | Q36835081 | ||
| Ongoing higher infection rate in ABO-incompatible kidney transplant recipient: is it a serious problem? A single-center experience | Q37088929 | ||
| ABO incompatible renal transplantation: a paradigm ready for broad implementation | Q37454277 | ||
| The First Fifty ABO Blood Group Incompatible Kidney Transplantations: The Rotterdam Experience | Q37615262 | ||
| Comparative analysis of ABO-incompatible living donor kidney transplantation with ABO-compatible grafts: a single-center experience in Korea | Q38445752 | ||
| Long-term Outcomes of ABO-Incompatible Living Donor Kidney Transplantation: A Comparative Analysis | Q38570443 | ||
| Preconditioning Therapy in ABO-Incompatible Living Kidney Transplantation: A Systematic Review and Meta-Analysis | Q38596560 | ||
| Analysis of 4000 kidney transplantations in a single center: Across immunological barriers | Q38924582 | ||
| Clinical Outcomes and Results of Pathological Findings of 1-year Protocol Biopsy in Recipients of ABO-Incompatible Living Donor Kidney Transplantants | Q39730018 | ||
| Clinical outcomes of ABO- and HLA-incompatible kidney transplantation: a nationwide cohort study. | Q40217293 | ||
| One hundred ABO-incompatible kidney transplantations between 2004 and 2014: a single-centre experience | Q40271255 | ||
| Histological Analysis in ABO-Compatible and ABO-Incompatible Kidney Transplantation by Performance of 3- and 12-Month Protocol Biopsies. | Q40621135 | ||
| The effect of rituximab dose on infectious complications in ABO-incompatible kidney transplantation. | Q40670409 | ||
| ABO desensitization affects cellular immunity and infection control after renal transplantation | Q40879749 | ||
| ABO-Incompatible Living Kidney Transplants: Evolution of Outcomes and Immunosuppressive Management | Q40915460 | ||
| Outcomes Following ABO-Incompatible Kidney Transplantation Performed After Desensitization by Nonantigen-Specific Immunoadsorption | Q41218014 | ||
| Clinical Outcome of Elderly Kidney Transplant Recipients from Spousal Donors | Q41514866 | ||
| Rituximab as induction therapy after renal transplantation: a randomized, double-blind, placebo-controlled study of efficacy and safety. | Q41527816 | ||
| Three-year outcomes following 1420 ABO-incompatible living-donor kidney transplants performed after ABO antibody reduction: results from 101 centers | Q42205063 | ||
| Outcome comparison of ABO-incompatible kidney transplantation with low-dose rituximab and ABO-compatible kidney transplantation: a single-center experience. | Q42229870 | ||
| ABO-incompatible kidney transplant recipients have a higher bleeding risk after antigen-specific immunoadsorption | Q43713630 | ||
| The 5-year outcome of ABO-incompatible kidney transplantation with rituximab induction | Q44135123 | ||
| Tailored desensitization strategies in ABO blood group antibody incompatible renal transplantation | Q44222425 | ||
| The superior results of living-donor renal transplantation are not completely caused by selection or short cold ischemia time: a single-center, multivariate analysis | Q44493633 | ||
| Successful results after 5 years of tacrolimus therapy in ABO-incompatible kidney transplantation in Japan | Q46512790 | ||
| ABO-incompatible kidney transplantation using antigen-specific immunoadsorption and rituximab: a 3-year follow-up | Q46518667 | ||
| The effect of desensitization therapy in kidney transplantation | Q47340562 | ||
| Neither pre-transplant rituximab nor splenectomy affects de novo HLA antibody production after renal transplantation. | Q47778948 | ||
| ABO-Incompatible Kidney Transplantation. | Q53656895 | ||
| Increase of infectious complications in ABO-incompatible kidney transplant recipients--a single centre experience. | Q54481297 | ||
| A highly efficient living donor kidney exchange program for both blood type and crossmatch incompatible donor-recipient combinations | Q79468521 | ||
| Complications, resource utilization, and cost of ABO-incompatible living donor kidney transplantation | Q79955710 | ||
| Excellent long-term outcome of ABO-incompatible living donor kidney transplantation in Japan | Q80198398 | ||
| Chronic antibody-mediated rejection is reduced by targeting B-cell immunity during an introductory period | Q82350692 | ||
| Excellent outcomes of ABO-incompatible kidney transplantation: a single-center experience | Q83396331 | ||
| Successful ABO-incompatible kidney transplantation with antibody removal and standard immunosuppression | Q83748536 | ||
| ABO incompatible renal transplants and decreased likelihood for developing immune responses to HLA and kidney self-antigens | Q86503813 | ||
| Differences in chronic intragraft inflammation between positive crossmatch and ABO-incompatible kidney transplantation | Q88042637 | ||
| Borderline rejection in ABO-incompatible kidney transplantation | Q89371448 | ||
| P433 | issue | 8 | |
| P921 | main subject | meta-analysis | Q815382 |
| P304 | page(s) | 1234-1243 | |
| P577 | publication date | 2018-07-16 | |
| P1433 | published in | Clinical Journal of the American Society of Nephrology | Q15757929 |
| P1476 | title | ABO-Incompatible Kidney Transplant Outcomes: A Meta-Analysis | |
| P478 | volume | 13 |
| Q98771845 | ABO-Incompatible Robotic-Assisted Kidney Transplantation in the Obese Recipient |
| Q95587740 | Clinical outcomes after ABO-incompatible renal transplantation |
| Q98727034 | Current protocols and outcomes of ABO-incompatible kidney transplantation |
| Q91899865 | Daratumumab for Treatment of Antibody-Mediated Rejection after ABO-Incompatible Kidney Transplantation |
| Q64084651 | Early hospital readmissions after ABO- or HLA- incompatible living donor kidney transplantation |
| Q104078024 | Effect of Different Rituximab Doses on B Cell Count, Anti-A/B Antibody Titer, Graft Function, and Infectious Complications in ABO-Incompatible Renal Transplantation: A Prospective Study |
| Q91657061 | Effect of simultaneous presence of anti-blood group A/B and -HLA antibodies on clinical outcomes in kidney transplantation across positive crossmatch: a nationwide cohort study |
| Q90252726 | Expand the Pool of Living Donors for Kidney Transplantation |
| Q89582269 | Individualized Preconditioning for ABO-Incompatible Living-Donor Kidney Transplantation: An Initial Report of 48 Cases from China |
| Q90112402 | Latest insights on ABO-incompatible living-donor renal transplantation |
| Q100517385 | Long-term Follow-up of ABO-Incompatible Kidney Transplantation in Freiburg, Germany: A Single-Center Outcome Report |
| Q92996524 | New rules of ABO-compatibility in kidney transplantation |
| Q64997155 | Pilot Experience with ABO-Incompatible Kidney Transplantation as a Second Transplant. |
Search more.